Atlas Capital Resources II LP 4
Accession 0001567619-19-021792
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 6:41 PM ET
Size
55.1 KB
Accession
0001567619-19-021792
Insider Transaction Report
- Sale
Common Stock, par value $0.01 per share
2019-11-14$3.60/sh−50,264$181,021→ 2,691,512 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2019-11-18$3.51/sh−13,127$46,015→ 2,656,758 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2019-11-15$3.52/sh−21,627$76,058→ 2,669,885 total(indirect: See footnotes)
- Sale
Common Stock, par value $0.01 per share
2019-11-14$3.60/sh−50,264$181,021→ 2,691,512 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2019-11-15$3.52/sh−21,627$76,058→ 2,669,885 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2019-11-18$3.51/sh−13,127$46,015→ 2,656,758 total(indirect: See footnotes)
- Sale
Common Stock, par value $0.01 per share
2019-11-18$3.51/sh−13,127$46,015→ 2,656,758 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2019-11-15$3.52/sh−21,627$76,058→ 2,669,885 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2019-11-14$3.60/sh−50,264$181,021→ 2,691,512 total(indirect: See footnotes)
- Sale
Common Stock, par value $0.01 per share
2019-11-14$3.60/sh−50,264$181,021→ 2,691,512 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2019-11-18$3.51/sh−13,127$46,015→ 2,656,758 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2019-11-15$3.52/sh−21,627$76,058→ 2,669,885 total(indirect: See footnotes)
- Sale
Common Stock, par value $0.01 per share
2019-11-18$3.51/sh−13,127$46,015→ 2,656,758 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2019-11-14$3.60/sh−50,264$181,021→ 2,691,512 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2019-11-15$3.52/sh−21,627$76,058→ 2,669,885 total(indirect: See footnotes)
- Sale
Common Stock, par value $0.01 per share
2019-11-15$3.52/sh−21,627$76,058→ 2,669,885 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2019-11-14$3.60/sh−50,264$181,021→ 2,691,512 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2019-11-18$3.51/sh−13,127$46,015→ 2,656,758 total(indirect: See footnotes)
Footnotes (5)
- [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.5000 to $3.8900. The Reporting Persons undertake to provide any securityholder of the Issuer, the Issuer or the Staff, upon request, full information regarding the number of shares traded at each separate price within the ranges set forth in this footnote to this Form 4.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.5000 to $3.5900. The Reporting Persons undertake to provide any securityholder of the Issuer, the Issuer or the Staff, upon request, full information regarding the number of shares traded at each separate price within the ranges set forth in this footnote to this Form 4.
- [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.5000 to $3.5400. The Reporting Persons undertake to provide any securityholder of the Issuer, the Issuer or the Staff, upon request, full information regarding the number of shares traded at each separate price within the ranges set forth in this footnote to this Form 4.
- [F4]Lapetus Capital II LLC, a Delaware limited liability company ("Lapetus") is the direct beneficial owner of 2,656,758 shares of Common Stock of the Issuer. Atlas Capital Resources II LP, a Delaware limited partnership ("ACR II"), is the majority and controlling member of Lapetus. Atlas Capital GP II LP, a Delaware limited partnership ("AC GP"), is the general partner of ACR II. Atlas Capital Resources GP II LLC, a Delaware limited liability company ("ACR GP"), is the general partner of AC GP. Lapetus, ACR II, AC GP and ACR GP are collectively referred to as the "Atlas Entities." Andrew M. Bursky and Timothy J. Fazio are each a Managing Partner of ACR GP, and may be deemed to control the Atlas Entities. By reason of the provisions of Rule 16a-1 of the Securities Exchange Act of 1934, as amended, each of the Atlas Entities, Mr. Bursky and Mr. Fazio may be deemed to have an indirect pecuniary interest in the shares of the Common Stock that are directly held by Lapetus.
- [F5]In accordance with Instruction 4(b)(iv), the entire amount of the shares of Common Stock that is owned by Lapetus is reported herein. Each of Mr. Bursky, Mr. Fazio, ACR II GP, AC GP and ACR GP disclaims beneficial ownership interest of the Common Stock except, in each case, to the extent it or he has any indirect pecuniary interest therein.
Issuer
Horizon Global Corp
CIK 0001637655
Related Parties
1- filerCIK 0001593630
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 6:41 PM ET
- Size
- 55.1 KB